Albany, NY -- (SBWIRE) -- 01/10/2018 -- Contraception is deliberate use of artificial methods or other techniques to prevent pregnancy as a consequence of sexual intercourse. Contraceptive devices are intended to prevent conception. These devices also help to prevent the spread of sexually transmitted infections. Various awareness initiatives taken by market players is a major factor propelling the global contraceptive devices market. Bayer HealthCare, a major player in the contraceptives market, in collaboration with 11 NGOs, organizes the World Contraception Day every year on September 26 to spread awareness about contraceptive methods, enabling young people to take the right decision about their reproductive health.
Report Overview @ https://www.transparencymarketresearch.com/contraceptive-devices-market.html
The global contraceptive devices market is expected to grow substantially due to factors such as high incidence rate of unintended pregnancies, unmet contraceptive needs, rise in awareness initiatives by governments and NGOs, and implementation of the Affordable Care Act. A high percentage of population belonging to the sexually active age group in Asia (India and China) coupled with increase in disposable incomes of consumers belonging to such economies is likely to offer significant opportunities in the contraceptive devices market. However, side effects associated with the use of contraceptive devices inducing people to opt for natural and permanent contraceptive methods, and rise in prevalence of infertility among women and aging population hamper the growth of the global contraceptive devices market
Based on type, the global contraceptive devices market can be segmented into male contraceptive devices and female contraceptive devices. Male contraceptive devices comprise male condoms. Female contraceptives include female condoms, contraceptive vaginal rings, contraceptive diaphragms, contraceptive sponges, sub-dermal contraceptive implants, intrauterine devices, and non-surgical permanent contraceptive devices. Male condoms dominate the male contraceptive devices segment due to almost universal adoption facilitated by ease of use and lowest prices. Non-surgical permanent contraceptive devices is projected to be the fastest growing sub-segment of the female contraceptives segment. Growing popularity among women who prefer to obtain permanent contraception without painful surgeries is the major factor propelling the non-surgical permanent contraceptive devices sub-segment. Based on end-user, the global contraceptive devices market can be divided into hospitals, clinics, ambulatory surgical centers, and home care.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35921
Geographically, the global contraceptive devices market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. North America dominates the global market due to high incidence rate of unplanned pregnancies, implementation of the Affordable Care Act in the U.S., and high usage of contraceptive devices in this region. Favorable reimbursement policies for contraceptives by large insurance firms for all federal employees (U.S.) and their dependents has contributed significantly to the growth of the contraceptive devices market in North America. The contraceptive devices market in Asia Pacific is expected to witness the fastest growth during the forecast period. Strong economic growth in India and China, high population, rise in disposable income, increase in awareness about contraceptives and its advantages for preventing pregnancy and sexually transmitted infections are expected to accelerate the growth of the market in the region during the forecast period.
Key players operating in the global contraceptive devices market include Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution, Inc., Actavis, Inc., Medicines360, Pace Pharmaceuticals Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Church & Dwight, Co., Inc., Merck & Co., Inc., Reckitt Benckiser plc, and Pfizer, Inc. These players focus on creating various awareness programs and providing contraceptives at cost effective prices to increase market share and sustain in the highly competitive market.
Pre-Book Full Report @ https://www.transparencymarketresearch.com
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.